Neurodiversity Celebration Week - Working With ADHD (Podcast)

High-stakes work doesn’t follow a clean process. Requirements shift, context changes, and what’s important isn’t always visible upfront. What begins as a straightforward request can quickly become something more complex. A legal contract revision expands after new stakeholders weigh in. A regulatory filing changes as new requirements emerge.

Gavin Tighe and Stephen Thiele dissect Mazaheri v Law Society of Ontario, 2026 ONLSTH 112, the first case in which "hallucinated" AI-generated authorities were placed before the Law Society Tribunal.

Jeff Davis, Chief Legal and Corporate Affairs Officer at Ontario Teachers' Pension Plan, discusses his unconventional leadership approach centered on vulnerability and psychological safety. From his 2019 award acceptance speech addressing mental health challenges in the legal profession to building an 80-person global team, Davis shares how embracing uncertainty and authentic self-expression has shaped both his 22-year career trajectory and his philosophy on managing complex risks in today's rapidly changin

Les 14 et 15 avril prochains, notre collègue Tina Hobday, associée, participera à la conférence virtuelle Professional Regulation and Discipline: New Tools, New Challenges, New Standards, organisée par le College of Health and Care Professionals de la Colombie-Britannique.

Torys law firm celebrates the graduation of its sixth cohort from the exclusive Torys-Rotman Business Leadership Program, a comprehensive training initiative designed to enhance lawyers' strategic thinking, leadership capabilities, and client relationship skills through interactive modules and collaborative learning experiences.

In-house legal departments are being asked to do more than manage risk. Across Canada, legal teams now carry responsibilities that extend well beyond traditional legal advice, such as compliance, investigations, government relations, and increasingly, company secretarial and ESG functions.

Il n’y a pas longtemps, un vendredi matin, Simar Anand se préparait pour la fin de semaine la plus occupée de l’année au Resto Darbar, sur le boulevard Saint-Laurent à Montréal. L’occasion? La fin de semaine du Grand Prix. La liste des réservations du restaurant de 40 places comptait des clients de partout dans le monde en raison de l’arrivée en ville de Max Verstappen, Lewis Hamilton, Lando Norris et compagnie.

On June 17, in-house lawyers filled the new offices of Henein Hutchison Robitaille LLP in Toronto, Canada, for an evening conversation with Marie Henein — one of Canada's most recognized legal advocates — on the future of the rule of law in Canada. Registration hit capacity well before the event, a signal of where the profession's attention is right now.

Senior in-house lawyers rarely get the space to think. The demands of the role are relentless - the urgent matter, the inbox, the open door - and genuine strategic thinking is hard to protect when the operational pull never stops. The conversations that actually need to happen get deferred, again and again, in favour of whatever is most pressing today.

The role of general counsel has changed considerably over the past decade. Where legal departments once operated primarily as internal advisors — reviewing contracts, managing disputes, ensuring compliance — today's senior in-house lawyers are increasingly expected to function as strategic business partners. They sit on executive committees. They advise on capital allocation and organizational design. They are present not just when legal issues arise, but at the table where the business is shaped.

Le Conseil d'examen du prix des médicaments brevetés (CEPMB) a lancé une consultation supplémentaire de 30 jours sur un projet de directives relatives à la pratique révisées...

Santé Canada a publié de nouvelles modifications réglementaires visant à renforcer sa capacité à prévenir et résoudre les pénuries de médicaments et d'instruments médicaux.

L'Agence des médicaments du Canada établit des principes directeurs pour l'utilisation de l'intelligence artificielle dans la génération de preuves cliniques du contexte réel.

The Patented Medicine Prices Review Board (PMPRB) has launched a second 30-day consultation on revised proposed Practice Directions for hearings related to excessive medicine pricing and compliance with filing requirements. The revised directions incorporate feedback from the initial consultation, with a summary chart detailing all edits available for stakeholder review.

Canada's Drug Agency has released new guidance on using artificial intelligence methods to generate real-world evidence for health technology assessments, establishing governance considerations and appraisal principles that emphasize transparency, human oversight, and validation. The agency also launched initiatives supporting precision medicine decision-making, including testing procedure assessments and a pan-Canadian framework for biomarker evaluation in cancer care.

Health Canada has published comprehensive amendments to drug and medical device shortage regulations, introducing expanded reporting requirements, extended expiration date authorities, and enhanced exceptional importation frameworks. The new measures grant the Minister of Health broader powers to prevent and respond to supply disruptions while requiring manufacturers to provide 12-month advance notice of discontinuations.

Health Canada has announced significant regulatory changes for medical device establishment licensing, set to take effect in December 2026. These Phase II amendments aim to streamline requirements...

Santé Canada modernise son processus d'octroi de licences d'établissement d'instruments médicaux avec des modifications réglementaires majeures entrant en vigueur en décembre 2026. Ces changements visent à alléger le fardeau réglementaire, promouvoir l'innovation et améliorer la compétitivité de l'industrie canadienne des dispositifs médicaux.

Santé Canada a obtenu une injonction permanente contre Canlab Research, interdisant la vente de peptides injectables non autorisés au Canada. Cette décision fait suite à des mesures coercitives répétées visant à protéger les consommateurs contre des produits non homologués présentant des risques graves pour la santé.

Santé Canada a lancé un nouveau portail de recherche des essais cliniques et publié une ligne directrice mise à jour sur l'enregistrement et la divulgation des résultats.